Cell Reports (Mar 2017)

Interrogation of Functional Cell-Surface Markers Identifies CD151 Dependency in High-Grade Serous Ovarian Cancer

  • Mauricio Medrano,
  • Laudine Communal,
  • Kevin R. Brown,
  • Marcin Iwanicki,
  • Josee Normand,
  • Joshua Paterson,
  • Fabrice Sircoulomb,
  • Paul Krzyzanowski,
  • Marian Novak,
  • Sasha A. Doodnauth,
  • Fernando Suarez Saiz,
  • Jane Cullis,
  • Rima Al-awar,
  • Benjamin G. Neel,
  • John McPherson,
  • Ronny Drapkin,
  • Laurie Ailles,
  • Anne-Marie Mes-Massons,
  • Robert Rottapel

DOI
https://doi.org/10.1016/j.celrep.2017.02.028
Journal volume & issue
Vol. 18, no. 10
pp. 2343 – 2358

Abstract

Read online

The degree of genetic aberrations characteristic of high-grade serous ovarian cancer (HGSC) makes identification of the molecular features that drive tumor progression difficult. Here, we perform genome-wide RNAi screens and comprehensive expression analysis of cell-surface markers in a panel of HGSC cell lines to identify genes that are critical to their survival. We report that the tetraspanin CD151 contributes to survival of a subset of HGSC cell lines associated with a ZEB transcriptional program and supports the growth of HGSC tumors. Moreover, we show that high CD151 expression is prognostic of poor clinical outcome. This study reveals cell-surface vulnerabilities associated with HGSC, provides a framework for identifying therapeutic targets, and reports a role for CD151 in HGSC.

Keywords